← Back to Search

Advertisement content (explicit vs. implicit) for Smoking (YLA Trial)

N/A
Waitlist Available
Led By Melissa Mercincavage, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights

YLA Trial Summary

This trial will study the effects of low nicotine content cigarette advertising on people's perceptions and use behaviors.

YLA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attention
Perceived health risks
Recall
+1 more
Secondary outcome measures
Attitudes
Purchasing behavior

YLA Trial Design

2Treatment groups
Experimental Treatment
Group I: SmokersExperimental Treatment2 Interventions
Smokers will be randomized to view an advertisement with either true or misleading and implicit or explicit harm messaging content.
Group II: Non-smokersExperimental Treatment2 Interventions
Non-smokers will be randomized to view an advertisement with either true or misleading and implicit or explicit harm messaging content.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,014 Previous Clinical Trials
42,892,616 Total Patients Enrolled
15 Trials studying Smoking
7,588 Patients Enrolled for Smoking
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
104,988 Total Patients Enrolled
4 Trials studying Smoking
391 Patients Enrolled for Smoking
National Cancer Institute (NCI)NIH
13,708 Previous Clinical Trials
40,932,673 Total Patients Enrolled
64 Trials studying Smoking
54,277 Patients Enrolled for Smoking

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current research protocol open to individuals aged 35 or older?

"In order to qualify for the trial, participants must be between 21 and 29 years of age."

Answered by AI

Is there a possibility for me to participate in this research endeavor?

"This medical trial is seeking approximately 340 participants aged 21 to 29 who have a history of smoking."

Answered by AI

Is recruitment for this trial still open to those wishing to participate?

"The information hosted on clinicaltrials.gov affirms that this investigation is actively seeking participants, having been initially posted on May 27th 2021 and recently amended June 15th 2022."

Answered by AI

How many participants are enrolled in this clinical research?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical research is open for enrollment and was first advertised on May 27th 2021 with the last update as recent as June 15 2022. The trial seeks 340 patients from one medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Average response time
  • < 1 Day
Most responsive sites:
  1. Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania: < 24 hours
Typically responds via
Email
~14 spots leftby May 2025